Skip to main content
OPRX logo

OPRX · OptimizeRx Corp · Earnings Call Transcripts & Audio

Track OPRX — free
$7.81 +0.52 (+7.13%) At close · Sep 14
Market Cap
$137.31M
Shares
18.84M

OptimizeRx Corp Earnings Call Transcripts

Quarterly earnings calls for OptimizeRx Corp (OPRX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-12
OptimizeRx Corp (OPRX) Q2 2026 Earnings Call Transcript
Positive tone Revenue and EBITDA performance AI-enabled product innovations Customer concentration and revenue softness
Revenue
$20.50M
▼ 29.8% YoY
Diluted EPS
$-0.04
▼ 150% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
OptimizeRx Corp (OPRX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-12
OptimizeRx Corp (OPRX) Q1 2026 Earnings Call Transcript
Balanced tone Adjusted EBITDA and Margin Discipline Programmatic / DSP Activation Opportunity Term Loan Refinancing
Revenue
$19.84M
▼ 9.5% YoY
Diluted EPS
$-0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Transcript
Positive tone Q4 and FY2025 financial performance Channel partners and competitive positioning DAP (Dynamic Audience Activation Platform)
Revenue
$32.24M*
▼ 0.2% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Transcript
Confident tone Rule of 40 and Profitability Omnichannel Platform and Technology Revenue Growth and Beat
Revenue
$26.07M
▲ 22.3% YoY
Diluted EPS
$0.04
Gross margin
67.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
OptimizeRx Corp (OPRX) Q2 2025 Earnings Call Transcript
Confident tone Revenue growth and financial outperformance Debt paydown and balance sheet Omnichannel platform and competitive positioning
Revenue
$29.20M
▲ 55.2% YoY
Diluted EPS
$0.08
Gross margin
63.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Transcript
Confident tone Gross margin and product mix Revenue growth and beat Pipeline and customer KPIs
Revenue
$21.93M
▲ 11.4% YoY
Diluted EPS
$-0.12
Gross margin
60.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Transcript
Confident tone 2025 guidance and growth outlook Rule of 40 and recurring revenue model HCP and DTC integration / competitive positioning
Revenue
$32.32M*
▲ 13.9% YoY
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Transcript
Positive tone DTC micro-neighborhood / self-service pivot Q3 revenue shortfall DAAP AI-driven omnichannel platform
Revenue
$21.31M
▲ 30.5% YoY
Diluted EPS
$-0.50
Gross margin
63.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
OptimizeRx Corp (OPRX) Q2 2024 Earnings Call Transcript
Positive tone DAAP conversion and momentum Medicx Health acquisition integration Full-year revenue guidance and visibility
Revenue
$18.81M
▲ 36.1% YoY
Diluted EPS
$-0.22
Gross margin
62.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-18
OptimizeRx Corp (OPRX) Q1 2024 Earnings Call Transcript
Confident tone DAAP (Dynamic Audience Activation Platform) Cross-sell and pipeline expansion Financial performance (gross margin, expenses, net loss)
Revenue
$19.69M
▲ 51.4% YoY
Diluted EPS
$-0.38
Gross margin
62.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-11
OptimizeRx Corp (OPRX) Q4 2023 Earnings Call Transcript
Confident tone DAAP Platform Growth Medicx Health Acquisition & Integration Cost Optimization
Revenue
$28.37M*
▲ 44.3% YoY
Gross margin
62.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
OptimizeRx Corp (OPRX) Q3 2023 Earnings Call Transcript
Revenue
$16.33M
▲ 8.3% YoY
Diluted EPS
$-0.17
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
OptimizeRx Corp (OPRX) Q2 2023 Earnings Call Transcript
Revenue
$13.82M
▼ 1.1% YoY
Diluted EPS
$-0.24
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
OptimizeRx Corp (OPRX) Q1 2023 Earnings Call Transcript
Revenue
$13.00M
▼ 5.3% YoY
Diluted EPS
$-0.37
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
OptimizeRx Corp (OPRX) Q4 2022 Earnings Call Transcript
Revenue
$19.65M*
▼ 3.2% YoY
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
OptimizeRx Corp (OPRX) Q3 2022 Earnings Call Transcript
Revenue
$15.09M
▼ 6.4% YoY
Diluted EPS
$-0.19
Gross margin
62.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
OptimizeRx Corp (OPRX) Q2 2022 Earnings Call Transcript
Revenue
$13.98M
▲ 2.6% YoY
Diluted EPS
$-0.21
▼ 1150% YoY
Gross margin
64.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
OptimizeRx Corp (OPRX) Q1 2022 Earnings Call Transcript
Revenue
$13.73M
▲ 22.3% YoY
Diluted EPS
$-0.21
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
OptimizeRx Corp (OPRX) Q4 2021 Earnings Call Transcript
Revenue
$20.31M*
▲ 23.7% YoY
Gross margin
61.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
OptimizeRx Corp (OPRX) Q3 2021 Earnings Call Transcript
Revenue
$16.12M
▲ 53.3% YoY
Diluted EPS
$0.00
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
OptimizeRx Corp (OPRX) Q2 2021 Earnings Call Transcript
Revenue
$13.63M
▲ 55.1% YoY
Diluted EPS
$0.02
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-28
OptimizeRx Corp (OPRX) Q1 2021 Earnings Call Transcript
Revenue
$11.23M
▲ 48.1% YoY
Diluted EPS
$-0.04
Gross margin
54.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
OptimizeRx Corp (OPRX) Q4 2020 Earnings Call Transcript
Revenue
$16.43M*
▲ 122.6% YoY
Gross margin
52.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-13
OptimizeRx Corp (OPRX) Q3 2020 Earnings Call Transcript
Revenue
$10.52M
▲ 110.3% YoY
Diluted EPS
$-0.02
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
OptimizeRx Corp (OPRX) Q2 2020 Earnings Call Transcript
Revenue
$8.78M
▲ 25.4% YoY
Diluted EPS
$-0.07
▼ 333.3% YoY
Gross margin
58.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
OptimizeRx Corp (OPRX) Q1 2020 Earnings Call Transcript
Revenue
$7.58M
▲ 45.6% YoY
Diluted EPS
$-0.15
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-28
OptimizeRx Corp (OPRX) Q4 2019 Earnings Call
Revenue
$7.38M*
▲ 12.2% YoY
Gross margin
60.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 1448431 CUSIP 68401U204 13F (30d) 3 filings 3 filers Visit website Investor relations